Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
6.67
+0.27 (4.22%)
At close: Aug 7, 2026, 4:00 PM EDT
6.70
+0.03 (0.45%)
After-hours: Aug 7, 2026, 7:34 PM EDT
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $707.25 million as of August 7, 2026. Its market cap has increased by 11.13% in one year.
Market Cap
707.25M
Enterprise Value
635.87M
1-Year Change
11.13%
Ranking
Category
Stock Price
$6.67
ChartMarket Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $707.25M, an increase of 37.22%. That is a compound annual growth rate of 12.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 707.25M | 10.22% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 733.66M |
| BridgeBio Oncology Therapeutics | 720.96M |
| Crescent Biopharma | 713.92M |
| Cybin | 707.24M |
| Neurogene | 693.66M |
| Zevra Therapeutics | 687.66M |
| Allogene Therapeutics | 683.41M |
| AgomAb Therapeutics NV | 680.61M |